Bio-Path Holdings, Inc.

BPTH

Exchange: OTC
Industry: Pharmaceutical Preparations
SEC CIK: 0001133818

SEC filings (opens in a new tab)

No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Bio-Path Holdings, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of BPTH: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	17	19	+2
Shares	412.2K	459.7K	+47.5K (+11.5%)
Value	$1.59M	$1.47M	−$128.0K (−8.0%)

New holders (3)

Institutions that held Bio-Path Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to BPTH in Q3 2022
Institution	Shares	Value	% of portfolio
Mount Yale Investment Advisors, LLC	25,350	$81.0K	0.01%
Virtu Financial LLC	12,090	$39.0K	0.00%
Citadel Advisors LLC	10,890	$35.0K	0.00%

Sold out (1)

Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of BPTH in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Captrust Financial Advisors	250	$1.00K